Changing the global obesity narrative to recognize and reduce weight stigma: a position statement from the World Obesity Federation

S Nutter, LA Eggerichs, TS Nagpal… - Obesity …, 2024 - Wiley Online Library
Weight stigma, defined as pervasive misconceptions and stereotypes associated with higher
body weight, is both a social determinant of health and a human rights issue. It is imperative …

[HTML][HTML] Obesity, diabetes mellitus, and cardiometabolic risk: an obesity medicine association (OMA) clinical practice statement (CPS) 2023

HE Bays, S Bindlish, TL Clayton - Obesity Pillars, 2023 - Elsevier
Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) is intended to provide clinicians an overview of type 2 diabetes mellitus (T2DM), an …

Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity

W Ghusn, A De la Rosa, D Sacoto… - JAMA Network …, 2022 - jamanetwork.com
Importance No retrospective cohort study has assessed the effectiveness of semaglutide at
doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). Objective To …

[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022

HE Bays, A Agarwala, C German, P Satish… - American Journal of …, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding …

Weight loss efficiency and safety of tirzepatide: A Systematic review

F Lin, B Yu, B Ling, G Lv, H Shang, X Zhao, X Jie… - PLoS …, 2023 - journals.plos.org
Objective Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-
dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight …

[HTML][HTML] Cancer and obesity: an obesity medicine association (OMA) clinical practice statement (CPS) 2022

E Lazarus, HE Bays - Obesity Pillars, 2022 - Elsevier
Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides an overview of cancer and increased body fat. Methods The scientific …

Highly expandable edible hydrogels for the prevention and treatment of obesity through dietary intervention

H Yang, H Yang, C Zhu, D Fan, J Deng - Food Hydrocolloids, 2023 - Elsevier
Long treatment periods, high risk of operation, and large side effects of drugs are the main
factors, affecting obesity treatment. Obesity prevention or treatment through dietary …

[HTML][HTML] Thirty obesity myths, misunderstandings, and/or oversimplifications: an obesity medicine association (OMA) clinical practice statement (CPS) 2022

HE Bays, A Golden, J Tondt - Obesity Pillars, 2022 - Elsevier
Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) is intended to provide clinicians an overview of 30 common obesity myths …

[HTML][HTML] Obesity and hypertension: obesity medicine association (OMA) clinical practice statement (CPS) 2023

TL Clayton, A Fitch, HE Bays - Obesity Pillars, 2023 - Elsevier
Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides an overview of the mechanisms and treatment of obesity and hypertension …

[HTML][HTML] Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review

HE Bays - Obesity Pillars, 2023 - Elsevier
Background A common adiposopathic complication of obesity is type 2 diabetes mellitus.
Healthful weight reduction in patients with obesity can improve glucose metabolism and …